TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12107244

Group type: EXPERIMENTAL
Intervention: Hypoglycemic clamp (glucose lowered to 2.5 mmol/liter)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Euglycemic clamp (glucose maintained at 5 mmol/liter)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Insulin infusion (80 mU/m(2).min) during euglycemic clamp
Number of subjects: 16

Group type: COMPARATOR
Intervention: Matched saline infusion (control group)
Number of subjects: 16
Study: 10221380

Group type: EXPERIMENTAL
Intervention: Surgical repair of abdominal aortic aneurysm (AAA) and elongation of the internal carotid artery (e‐ICA) in 25 patients (58.1%)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group of 141 e‐ICA subjects with no AAA
Number of subjects: 43
Study: 7554700

Group type: EXPERIMENTAL
Intervention: 10 mg loratadine every morning plus 500 mg erythromycin stearate every 8 hours
Number of subjects: 24

Group type: COMPARATOR
Intervention: 10 mg loratadine every morning plus placebo every 8 hours
Number of subjects: 24

Group type: COMPARATOR
Intervention: placebo every morning plus 500 mg erythromycin stearate
Number of subjects: 24
Study: 1980981

Group type: EXPERIMENTAL
Intervention: Clobetasol-17-propionate (CP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Crude coal tar (CT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dithranol (10% for 2 hours)
Number of subjects: 0
Study: 6243916

Group type: EXPERIMENTAL
Intervention: Topical ampicillin sodium
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Polyglycolic acid sutures
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Silk sutures
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Postoperative seromas or hematomas
Number of subjects: 398

Group type: COMPARATOR
Intervention: Cholecystectomies
Number of subjects: 398

Group type: COMPARATOR
Intervention: Hernia repairs
Number of subjects: 398
Study: 30566417

Group type: EXPERIMENTAL
Intervention: Paliperidone palmitate
Number of subjects: 84

Group type: COMPARATOR
Intervention: Second-generation oral antipsychotics
Number of subjects: 84
Study: 28363637

Group type: EXPERIMENTAL
Intervention: 400 mg DSM265 1 day before CHMI
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Atovaquone-proguanil (250-100 mg) 1 day before CHMI
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 400 mg DSM265 7 days before CHMI
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo 1 day before CHMI
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo 7 days before CHMI
Number of subjects: 22
Study: 25826326

Group type: EXPERIMENTAL
Intervention: Generic diclofenac
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Generic ketorolac
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Brand bromfenac
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Brand nepafenac
Number of subjects: 10
Study: 23873711

Group type: EXPERIMENTAL
Intervention: Cognitive-affective symptoms of depression in patients younger than 70 years
Number of subjects: 1823

Group type: EXPERIMENTAL
Intervention: Hopelessness in patients younger than 70 years
Number of subjects: 1823

Group type: EXPERIMENTAL
Intervention: Somatic symptoms in patients younger than 70 years
Number of subjects: 1823

Group type: EXPERIMENTAL
Intervention: Age, disease severity, and comorbidities in patients 70 years or older
Number of subjects: 1823

Group type: EXPERIMENTAL
Intervention: Overall outcome for patients (both age groups)
Number of subjects: 1823
Study: 21378389

Group type: EXPERIMENTAL
Intervention: Intensive glucose control (target glucose 80‐120 mg/dl)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Conventional glucose control (target glucose 180 mg/dl or less)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Intensive glucose control
Number of subjects: 115
Study: 19286590

Group type: COMPARATOR
Intervention: Placebo arm of a Phase IIb trial of recombinant activated Factor VII
Number of subjects: 90
Study: 17166646

Group type: EXPERIMENTAL
Intervention: Group therapy
Number of subjects: 93
Study: 15518835

Group type: EXPERIMENTAL
Intervention: PEEK fusion (Group A)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: AICG fusion and plate fixation (Group B)
Number of subjects: 180

Group type: COMPARATOR
Intervention: AICG only (Group C)
Number of subjects: 180
Study: 11449027

Group type: EXPERIMENTAL
Intervention: rTMS of left PFC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: rTMS of right PFC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mood self-rating
Number of subjects: 0
Study: 9116805

Group type: EXPERIMENTAL
Intervention: Neuromuscular stimulation (NMS) of the finger and wrist flexors and extensors for 30 minutes
Number of subjects: 8

Group type: COMPARATOR
Intervention: Limb elevation for 30 minutes
Number of subjects: 8
Study: 8429639

Group type: EXPERIMENTAL
Intervention: Bioimpedance (BI)
Number of subjects: 10
Study: 3315698

Group type: EXPERIMENTAL
Intervention: Epirubicin, vincristine and prednisolone (EVP)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cyclophosphamide, vincristine and prednisolone (CVP)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cyclophosphamide, epirubicin, vincristine and prednisolone (CEOP)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Epirubicin
Number of subjects: 100
Study: 31810741

Group type: EXPERIMENTAL
Intervention: Periodontal treatment
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (no periodontal treatment)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Intergroup comparison
Number of subjects: 48
Study: 29549863

Group type: EXPERIMENTAL
Intervention: Appetite Awareness Treatment (AAT)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Wait-list control group (WAIT)
Number of subjects: 31
Study: 26130657

Group type: EXPERIMENTAL
Intervention: Hydrotherapy (n=14), 45 minutes per session, five days a week for four weeks
Number of subjects: 28

Group type: COMPARATOR
Intervention: Land-based therapy (Control group, n=14), 45 minutes per session, five days a week for four weeks
Number of subjects: 28
Study: 25577782

Group type: COMPARATOR
Intervention: Celiprolol 100-200mg (C group)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Bisoprolol 2.5-5mg (B group)
Number of subjects: 102
Study: 23632946

Group type: EXPERIMENTAL
Intervention: Fingolimod 0.5 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intramuscular interferon beta (IFNβ)‐1a
Number of subjects: 0
Study: 19662337

Group type: EXPERIMENTAL
Intervention: t‐PA antigen
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: VWF
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: MMP‐3
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: BNP
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: MMP‐9
Number of subjects: 100
Study: 18621519

Group type: EXPERIMENTAL
Intervention: Formoterol 12 microg twice daily for 5 days
Number of subjects: 22
Study: 16085366

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) and contingency management (CM)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control (neither CBT nor CM)
Number of subjects: 81
Study: 12888042

Group type: EXPERIMENTAL
Intervention: 0.25 mg/ml ICG
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 0.5 mg/ml ICG
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 1.25 mg/ml ICG
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (0.25 mg/ml and 0.5 mg/ml ICG)
Number of subjects: 28
Study: 10472355

Group type: EXPERIMENTAL
Intervention: Photon therapy (median dose 60 Gy, range 45 to 65 Gy)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Neutron therapy (median dose 14.1 Gy, range 5.0 to 18.57 Gy)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Mixed-beam irradiation (average dose 36.5 Gy photon and 8.5 Gy neutrons)
Number of subjects: 161
Study: 8923090

Group type: EXPERIMENTAL
Intervention: Recombinant human interferon gamma 100 ug subcutaneously daily for up to 21 days
Number of subjects: 416

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 416
Study: 1762007

Group type: EXPERIMENTAL
Intervention: Ender nailing
Number of subjects: 220

Group type: COMPARATOR
Intervention: Sliding screw plate (SSP)
Number of subjects: 220
Study: 6760063

Group type: EXPERIMENTAL
Intervention: 4.5 mg/kg theophylline solution administered at 9 a.m.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 4.5 mg/kg theophylline solution administered at 9 p.m.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 4.5 mg/kg theophylline solution (both morning and evening)
Number of subjects: 8
Study: 3882015

Group type: EXPERIMENTAL
Intervention: Selective vagotomy with pyloroplasty
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Selective proximal vagotomy with pyloroplasty
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Selective proximal vagotomy
Number of subjects: 161

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 161
Study: 30017826

Group type: EXPERIMENTAL
Intervention: Combination treatment of vilanterol (25 μg) + fluticasone furoate (100 μg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14

Group type: COMPARATOR
Intervention: Fluticasone furoate (100 μg)
Number of subjects: 14
Study: 26613661

Group type: EXPERIMENTAL
Intervention: Survivors with short education
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Survivors living alone
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Fully adjusted model
Number of subjects: 369
Study: 25062857

Group type: EXPERIMENTAL
Intervention: 24-hour retest interval
Number of subjects: 34

Group type: COMPARATOR
Intervention: >6-days retest interval
Number of subjects: 34
Study: 22407175

Group type: EXPERIMENTAL
Intervention: Intra-observer variability in measurements of bidimensional products (BPs) of tumor diameter
Number of subjects: 10
Study: 19958206

Group type: EXPERIMENTAL
Intervention: 35% CO(2) mixture
Number of subjects: 15

Group type: COMPARATOR
Intervention: Atmospheric compressed air
Number of subjects: 15
Study: 18936577

Group type: EXPERIMENTAL
Intervention: Minimally invasive coronary artery bypass grafting (miniCABG)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Traditional sternotomy CABG
Number of subjects: 200
Study: 15897793

Group type: EXPERIMENTAL
Intervention: $5 prepaid monetary incentive
Number of subjects: 3900

Group type: EXPERIMENTAL
Intervention: Lottery incentive (chance to win one of ten $100 prize drawings)
Number of subjects: 3900

Group type: COMPARATOR
Intervention: No incentive
Number of subjects: 3900
Study: 14703410

Group type: EXPERIMENTAL
Intervention: Gene therapy + radiotherapy (GTRT group, n = 16)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Radiotherapy (RT group, n = 213)
Number of subjects: 29
Study: 10617311

Group type: EXPERIMENTAL
Intervention: Cue exposure (CE)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (neutral beverage)
Number of subjects: 50
Study: 8538479

Group type: EXPERIMENTAL
Intervention: Estradiol valerate (EV, 2 mg/day for 21 days) with cyproterone acetate (CPA, 1 mg/day in the last 10 days of the treatment cycle)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Oral calcium (500 mg/day)
Number of subjects: 31
Study: 1659358

Group type: EXPERIMENTAL
Intervention: Oat bran bread
Number of subjects: 12

Group type: COMPARATOR
Intervention: Wheat bran bread
Number of subjects: 12
Study: 7333345

Group type: EXPERIMENTAL
Intervention: Theolair Retard 250 mg sustained release tablet
Number of subjects: 8
Study: 31608677

Group type: EXPERIMENTAL
Intervention: Outpatient balance training intervention (4 weeks)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Domiciliary balance training intervention (4 weeks)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (normal activities)
Number of subjects: 86
Study: 30218653

Group type: EXPERIMENTAL
Intervention: Double-barrel fibular flap (DBFF)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Single-barrel fibular flap (SBFF)
Number of subjects: 26
Study: 30419858

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy added to chemo-radiotherapy
Number of subjects: 85
Study: 26922296

Group type: EXPERIMENTAL
Intervention: Pitavastatin 4 mg
Number of subjects: 312

Group type: COMPARATOR
Intervention: Pravastatin 40 mg
Number of subjects: 312
Study: 23135413

Group type: EXPERIMENTAL
Intervention: Cemented tibial fixation (n=48)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Cementless fixation with screw augmentation (n=45)
Number of subjects: 93
Study: 25324618

Group type: EXPERIMENTAL
Intervention: Integrated rehabilitation program
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (routine outpatient care)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Guardians of patients in the intervention group
Number of subjects: 90

Group type: COMPARATOR
Intervention: Guardians of patients in the control group
Number of subjects: 90
Study: 20193089

Group type: EXPERIMENTAL
Intervention: Yoga practice for one hour daily for one week
Number of subjects: 22

Group type: COMPARATOR
Intervention: Non-yoga wait-list control group
Number of subjects: 22
Study: 18072052

Group type: EXPERIMENTAL
Intervention: 1 L of polyethylene glycol (PEG) solution
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 2 L of polyethylene glycol (PEG) solution
Number of subjects: 90

Group type: COMPARATOR
Intervention: Clear liquid diet and overnight fast (no PEG solution)
Number of subjects: 90
Study: 16271342

Group type: EXPERIMENTAL
Intervention: 6‐mg nicotine enemas
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo enemas
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: 6‐mg nicotine enemas in patients taking mesalamine
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo enemas in patients taking mesalamine
Number of subjects: 104
Study: 11583888

Group type: EXPERIMENTAL
Intervention: GTN, 0.6 mg/h/24 h for six days
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (no therapy)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (SNP)
Number of subjects: 16
Study: 9622211

Group type: EXPERIMENTAL
Intervention: Bemiparin (therapeutic subcutaneous doses)
Number of subjects: 0
Study: 7888287

Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Metoprolol CR/Z0K 100 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Metoprolol CR/Z0K 50 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 3352163

Group type: EXPERIMENTAL
Intervention: Branched-chain amino acids (BCAA) infusion
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Amino acids mixture
Number of subjects: 5

Group type: COMPARATOR
Intervention: 0.9% saline solution
Number of subjects: 5
Study: 31857313

Group type: EXPERIMENTAL
Intervention: Electronic version of the Evaluating Respiratory Symptoms in COPD (E-RS)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Paper version of the Evaluating Respiratory Symptoms in COPD (E-RS)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Electronic version of the COPD Assessment Test (CAT)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Paper version of the COPD Assessment Test (CAT)
Number of subjects: 81
Study: 28835380

Group type: EXPERIMENTAL
Intervention: BL-8040 (1 mg/kg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: BL-8040 (0.5 mg/kg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: BL-8040 (0.75 mg/kg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 26193372

Group type: EXPERIMENTAL
Intervention: Face-down positioning (fdp)
Number of subjects: 30
Study: 23669458

Group type: EXPERIMENTAL
Intervention: Programs that accepted public insurance
Number of subjects: 13328

Group type: EXPERIMENTAL
Intervention: Programs with staff involvement and linkages with minority communities
Number of subjects: 13328

Group type: EXPERIMENTAL
Intervention: Programs with culturally responsive policies and assessment and treatment practices
Number of subjects: 13328
Study: 21306916

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (acceleration: from 12 to 89 ms(‐2))
Number of subjects: 23

Group type: COMPARATOR
Intervention: Conventional squat exercise on Smith machine (weight: from 20 to 70 kg)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Whole-body vibration
Number of subjects: 23

Group type: COMPARATOR
Intervention: Conventional squat exercise on Smith machine
Number of subjects: 23
Study: 19301201

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 17226044

Group type: EXPERIMENTAL
Intervention: Tibolone (21 days treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Estradiol-only (E(2))
Number of subjects: 0

Group type: COMPARATOR
Intervention: E(2) + Medroxyprogesterone Acetate (E(2) + MPA)
Number of subjects: 0
Study: 15490767

Group type: EXPERIMENTAL
Intervention: Couple therapy included in inpatient treatment (15 patients)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Standard inpatient treatment without partner therapy (16 patients)
Number of subjects: 31
Study: 11902819

Group type: EXPERIMENTAL
Intervention: Combined hormone replacement therapy (oestradiol 2 mg and norethisterone acetate 1 mg per day)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 9357881

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 48
Study: 7680947

Group type: EXPERIMENTAL
Intervention: Peritoneovenous shunts (PVS)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Abdominal paracentesis
Number of subjects: 85
Study: 3081935

Group type: EXPERIMENTAL
Intervention: Alcohol placebo
Number of subjects: 14

Group type: COMPARATOR
Intervention: Distilled water (Control)
Number of subjects: 14
Study: 31574544

Group type: EXPERIMENTAL
Intervention: Hydrogen Rich Water (HRW)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 29247498

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 48
Study: 27046802

Group type: EXPERIMENTAL
Intervention: Yoga (24 classes, 45 minutes each, during 3 months)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Qigong (12 classes, 90 minutes each, during 3 months)
Number of subjects: 176

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 176
Study: 24235081

Group type: EXPERIMENTAL
Intervention: Velcalcetide 0.5 mg
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Velcalcetide 2 mg
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Velcalcetide 5 mg
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Velcalcetide 10 mg
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Velcalcetide
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 22777096

Group type: EXPERIMENTAL
Intervention: JE-CV from industrial scale lot (n = 899)
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: JE-CV from development lot (n = 199)
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Hepatitis A control vaccine (n = 102)
Number of subjects: 1200
Study: 19737735

Group type: EXPERIMENTAL
Intervention: Participatory ergonomics intervention (n=59)
Number of subjects: 504

Group type: COMPARATOR
Intervention: Control group (n=60)
Number of subjects: 504
Study: 18176316

Group type: EXPERIMENTAL
Intervention: Septic shock context for cardiomyopathy case
Number of subjects: 0

Group type: COMPARATOR
Intervention: Uneventful clinic visit context for cardiomyopathy case
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lung cancer case presented before cardiomyopathy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lung cancer case presented after cardiomyopathy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phrasing of inquiry for lung cancer
Number of subjects: 0
Study: 16125368

Group type: EXPERIMENTAL
Intervention: Cannabis use
Number of subjects: 1580

Group type: EXPERIMENTAL
Intervention: Prevention against cannabis use
Number of subjects: 1580
Study: 12891099

Group type: EXPERIMENTAL
Intervention: Radiofrequency obliteration (RFO)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Stripping and high ligation (S&L)
Number of subjects: 85
Study: 10561349

Group type: EXPERIMENTAL
Intervention: Dartmouth regimen (dacarbazine 220 mg/m², cisplatin 25 mg/m² days 1 to 3, carmustine 150 mg/m² day 1 every other cycle, tamoxifen 10 mg orally bid)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Dacarbazine 1,000 mg/m²
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Dartmouth regimen
Number of subjects: 240

Group type: COMPARATOR
Intervention: Dacarbazine
Number of subjects: 240
Study: 8556879

Group type: EXPERIMENTAL
Intervention: Oral sensorimotor treatment (OST)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Chewing exercises alone
Number of subjects: 35

Group type: COMPARATOR
Intervention: Oral sensorimotor treatment (OST) and Chewing exercises
Number of subjects: 35
Study: 8369192

Group type: EXPERIMENTAL
Intervention: Aqueous solution of iohexol (9 mg I/ml)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Viscous preparation of iohexol (9 mg I/ml)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aqueous solution of amidotrizoate (9 mg I/ml)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aqueous solutions of iohexol and amidotrizoate
Number of subjects: 0
Study: 3530610

Group type: EXPERIMENTAL
Intervention: Adenosine with Methacholine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Methacholine-Methacholine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Adenosine-Adenosine
Number of subjects: 8
Study: 30287601

Group type: EXPERIMENTAL
Intervention: Cognitively Based Compassion Training (CBCT®-fC) for couples, duration 10 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (control condition)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitively Based Compassion Training (CBCT®-fC) for couples
Number of subjects: 0
Study: 27182021

Group type: EXPERIMENTAL
Intervention: Auricular acupressure using vaccaria seeds
Number of subjects: 58
Study: 24019207

Group type: EXPERIMENTAL
Intervention: Probiotic yogurt with low calorie diet (PLCD)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Probiotic yogurt without low calorie diet (PWLCD)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Regular yogurt as part of a low calorie diet (RLCD)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 75